It also addresses the FDA’s communications Using the applicant, the retention of documents that guidance the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant might transfer possession of an SE report to a brand new applicant and Digital submission with the SE report and amendments.T